21 related articles for article (PubMed ID: 31609767)
1. Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome.
Rosário JDS; Moreira FH; Rosa LHF; Guerra W; Silva-Caldeira PP
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570891
[TBL] [Abstract][Full Text] [Related]
2. One-pot synthesis of 2-arylated and 2-alkylated benzoxazoles and benzimidazoles based on triphenylbismuth dichloride-promoted desulfurization of thioamides.
Koyanagi A; Murata Y; Hayakawa S; Matsumura M; Yasuike S
Beilstein J Org Chem; 2022; 18():1479-1487. PubMed ID: 36320343
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of nuclear factor (erythroid-derived 2)-like 2 protein level in the human colorectal adenocarcinoma cell line DLD-1 by a heterocyclic organobismuth(III) compound: Effect of organobismuth(III) compound on NRF2 signaling.
Iuchi K; Tasaki Y; Shirai S; Hisatomi H
Biomed Pharmacother; 2020 May; 125():109928. PubMed ID: 32004978
[TBL] [Abstract][Full Text] [Related]
4. Heterocyclic organobismuth (III) compounds containing an eight-membered ring: Inhibitory effects on cell cycle progression.
Iuchi K; Yagura T
Toxicol In Vitro; 2018 Aug; 50():172-178. PubMed ID: 29574240
[TBL] [Abstract][Full Text] [Related]
5. Heterocyclic organobismuth(III) induces apoptosis of human promyelocytic leukemic cells through activation of caspases and mitochondrial perturbation.
Iuchi K; Hatano Y; Yagura T
Biochem Pharmacol; 2008 Oct; 76(8):974-86. PubMed ID: 18760261
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic organobismuth(III) compound targets tubulin to induce G2/M arrest in HeLa cells.
Iuchi K; Akagi K; Yagura T
J Pharmacol Sci; 2009 Apr; 109(4):573-82. PubMed ID: 19352070
[TBL] [Abstract][Full Text] [Related]
7. Studies on the cytotoxicity and anticancer performance of heterocyclic hypervalent organobismuth(III) compounds.
Liu YP; Lei J; Tang LW; Peng Y; Au CT; Chen Y; Yin SF
Eur J Med Chem; 2017 Oct; 139():826-835. PubMed ID: 28865278
[TBL] [Abstract][Full Text] [Related]
8. Caspase inhibitors promote alternative cell death pathways.
Vandenabeele P; Vanden Berghe T; Festjens N
Sci STKE; 2006 Oct; 2006(358):pe44. PubMed ID: 17062895
[TBL] [Abstract][Full Text] [Related]
9. Nonapoptotic Cell Death Pathways.
Green DR
Cold Spring Harb Perspect Biol; 2022 Nov; 14(11):. PubMed ID: 36319068
[No Abstract] [Full Text] [Related]
10. Heterocyclic organobismuth(III) compound induces nonapoptotic cell death via lipid peroxidation.
Iuchi K; Shirai S; Tasaki Y; Hisatomi H
Anticancer Drugs; 2020 Jan; 31(1):55-59. PubMed ID: 31609767
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
